<p>The invention provides human engineered antibodies, antigen-binding fragments thereof, that bind to, and inhibit the activity of, human DKK-1, and which are effective in treating diseases in which pathogenesis is mediated by DKK-1.</p>
申请公布号
KR20140033523(A)
申请公布日期
2014.03.18
申请号
KR20147005305
申请日期
2010.04.06
申请人
ELI LILLY AND COMPANY
发明人
CHEDID MARCIO;DARLING RYAN JAMES;GALVIN RACHELLE JEANETTE;SWANSON BARBARA ANNE
